Biologics Spine BioRestorative Completes Patient Enrollment in Landmark Phase 2 Trial of BRTX-100 for Chronic Lumbar Disc Disease byTim AllenFebruary 10, 2026
Hospitals Hospital for Special Surgery Deploys Advanced AI to Enhance Patient Access and Accelerate Care Delivery byTim AllenJanuary 28, 2026
Spine Aclarion Announces First Patient Enrollments at Two Additional CLARITY Trial Sites and Provides Guidance on Expected Availability of Initial Data byTim AllenJanuary 7, 2026
Sports Medicine NEXTBIOMEDICAL Announces First Patient Enrolled in U.S. FDA Pivotal Trial of Nexsphere-F™ for Knee Osteoarthritis Pain byJosh SandbergOctober 13, 2025
Biologics Spine Cerapedics Announces First U.S. Patient Treated with PearlMatrix™ P-15 Peptide Enhanced Bone Graft following FDA approval byTim AllenJuly 8, 2025
Extremities Top Stories Alafair Biosciences Announces First Patient Enrolled in Multi-Center Study Evaluating VersaWrap® Tendon Protector for Achilles Repair byBree MillerJune 25, 2025
Spine ReGelTec Announces First Patient Treated in U.S. IDE Clinical Trial for HYDRAFIL System to Treat Chronic Low Back Pain byJosh SandbergJune 18, 2025
Spine Memorial Neurosurgeons Deliver Spine-Tingling Outcome for Adult Scoliosis Patient byJosh SandbergFebruary 25, 2025
Spine SI-BONE, Inc. Announces First-In-Patient Procedures with FDA Breakthrough Device for Pelvic Fracture Fixation byJosh SandbergOctober 10, 2024
